‘Interventional cardiology’ is a branch of cardiology that focuses on catheter-based technologies for the treatment of structural heart diseases. Catheterization is used to perform large number of procedures on heart. It involves the insertion of a sheath into the femoral artery or any large peripheral artery or vein, and cannulating the heart under X-ray visualization (commonly known as fluoroscopy). However, numerous interventional devices are used for treating peripheral vascular disorders that affect the circulatory system, resulting in plaque built-up in the arteries of arms and legs. Some of the interventional devices used in the market include balloons, catheters, guidewires, stents, and filters.
Check the DISCOUNT on this report @ http://www.orbisresearch.com/contacts/discount/220775 .
The world interventional cardiology & peripheral vascular devices market was $13,203 million in 2015 and is expected to reach $25,349 million by 2022 with a CAGR of 9.7%. Rise in prevalence of cardiovascular disorders, geriatric population, demand for minimally invasive procedures, and rapid technological advancements in these devices driven the market. According to the American Heart Association, approximately 5.5 million individuals are affected by heart failure in the U.S., and approximately 670,000 new cases of heart failure are diagnosed every year. According to the Heart & Stroke Foundation, Canada, approximately 66,000 Canadians succumbed to cardiac abnormalities and stroke in 2012. These estimates are expected to boost the demand for interventional cardiology & peripheral vascular devices in the coming years.
On the other hand, complications related to implantation of interventional cardiology & peripheral vascular devices, product recall & failure, and availability of effective conventional treatment options restrict the market growth. Conversely, development of bioabsorbable stents offers key opportunity to market players. Unfavorable reimbursement policies for interventional cardiology & peripheral vascular devices across various regions (mainly the developing countries) are major hindrances for the market growth.
The report segments the market based on product and geography. Based on product, the market is classified into angioplasty balloons, angioplasty stents, angioplasty catheters, endovascular aneurysm repair stent grafts, inferior vena cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, and accessories. Angioplasty stents accounted for the major share of market in 2015; whereas plaque modification devices are the fastest growing segment during the forecast period. Plaque modification before a stent implant decreases the chance of restenosis. In addition, increase in prevalence of atherosclerosis and rise in obese population globally also fuel growth of these devices. Based on geography, the market is divided into North America, Europe, Asia-Pacific, and LAMEA regions North America accounted for the major share of the overall market in 2015, and Asia-Pacific is expected to be the fastest growing segment during the analysis period.
The market has witnessed several product launches and approvals in the recent years. For instance, in July 2016, Abbott Laboratories received FDA approval for Absorb bioresorbable heart stent. Absorb is a fully dissolvable stent for treatment of coronary artery diseases. This product launch not only enhanced the company’s vascular business, but also provided a better treatment option for blocked vessels of heart.
Purchase a copy of this report @ http://www.orbisresearch.com/contact/purchase/220775 .
The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
The report provides a quantitative analysis for the period of 2014–2022 to enable stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the market based on product helps understand the type of devices used for treating blockages associated with chronic diseases.
Competitive intelligence highlights the business practices followed by leading players across various regions.
Comprehensive analysis of all geographic regions helps determine the prevailing opportunities in these regions.
Key market players and their strategies are analyzed to understand the competitive outlook of the global market.
Extensive analysis of the market is conducted by following key product positioning and monitoring the top contenders within the market framework.
For more information contact email@example.com
Some Point’s from Table of Content:
Chapter 1 Introduction
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Key players
1.5 Research methodology
1.5.1 Secondary research
1.5.2 Primary research
1.5.3 Analyst tools and models
Chapter 2 Executive Summary
2.1 CXO perspective
Chapter 3 Market Overview
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top investment pockets
3.2.2 Top winning strategies
184.108.40.206 Competitive intelligence of companies and their strategies
3.3 Market share analysis, 2015
3.4 Market dynamics
220.127.116.11 Growing geriatric population and increasing prevalence of chronic diseases
18.104.22.168 Technological advancements
22.214.171.124 Improving healthcare infrastructure in developing countries
126.96.36.199 Development of minimally invasive procedures
188.8.131.52 Increasing patient awareness
184.108.40.206 High treatment cost
220.127.116.11 Stringent approval process for interventional cardiology and peripheral vascular devices
18.104.22.168 Huge market opportunities in developing countries
22.214.171.124 Development of Bioabsorbable stents
3.5 Clinical Trials
Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/220775 .
For any enquires before buying, connect with us @ firstname.lastname@example.org
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway, Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research
Follow us on Twitter: https://twitter.com/orbisresearch
Like us on Facebook: https://www.facebook.com/OrbisResearch